Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
The company, which has around £15mln in the bank, believes the strategic ‘pivot’ will see the business break even at the EBITDA level in the second half
"This highly earnings enhancing acquisition of US rights to Proleukin is significant to the whole group, not just the commercial medicines division,” said chief executive Shaun Chilton
“With this funding and growing revenues, the cash position remains strong and sufficient to cover the delivery of existing commercial plans,” investors were told
First-in-man studies of the ROCK2 technology will take place next year
China has more high-speed railroad than anywhere else in the world, but why? And how did it achieve this status in less than a decade?
Dr Cath O'Neill told investors: "I am determined to find a suitable individual for the CEO role with the same passion for the science, as well as commercial acumen"
The Food & Drug Administration has requested more data on the company's antibiotic
A 46-carat stone it found in December recently sold for more than US$1mln
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.